PSA-activated proaerolysin as a prostate specific cancer therapy
Native proaerolysin is a channel-forming bacterial protoxin that is activated upon cleavage by host proteases such as furin. PRX302 is an engineered form of proaerolysin in which the furin cleavage site has been replaced with a sequence known to be preferred by the protease, prostate specific antige...
محفوظ في:
| المؤلف الرئيسي: | Abi-Habib, Ralph (author) |
|---|---|
| مؤلفون آخرون: | Browning, Jeff L. (author), Singh, Ravibhushan (author), Carter, Carol (author), Ortiz, Janelle (author) |
| التنسيق: | conferenceObject |
| منشور في: |
2006
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/8051 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://cancerres.aacrjournals.org/content/66/8_Supplement/514.4.short |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Recombinant prostate-specific antigen proaerolysin shows selective protease sensitivity and cell cytotoxicity
حسب: Abi-Habib, Ralph
منشور في: (2007) -
A PSA-activated protoxin (PRX302) administered transperineally to men with BPH is well tolerated and induces reduction in prostate volume and symptomatic relief
حسب: Abi-Habib, Ralph J.
منشور في: (2009) -
Characterization of urokinase plasminogen activator-activated recombinant anthrax toxin for targeted cancer therapy
حسب: Abi-Habib, Ralph J.
منشور في: (2006) -
1787 evaluation of transperineal prostatic administration of a PSA-activasted protoxin (PRX302) in men with luts secondary to BPH
حسب: Elhilali, Mostafa
منشور في: (2010) -
Bone-targeted therapies in metastatic castration-resistant prostate cancer
حسب: El-Amm, Joelle
منشور في: (2013)